23 Jul, 2026
According to Straits Research, the global proton therapy market size was valued at $2.18 billion in 2025 and is projected to reach $4.63 billion by 2034, registering a CAGR of 8.75% during the forecast period 2026–2034.
The growth of the proton therapy market is primarily driven by the rising global prevalence of cancer and the increasing demand for highly precise and minimally invasive radiation treatments. Advancements in imaging, beam delivery, and treatment planning technologies have enhanced the safety and accuracy of proton therapy, making it a preferred option for tumors located near critical organs and for pediatric cases. However, the market faces restraints due to the high installation and maintenance costs of proton therapy facilities, limited availability of specialized infrastructure, and a shortage of trained professionals, which collectively restrict access, particularly in developing regions. Despite these challenges, significant opportunities lie in the expansion of compact and single-room proton systems, growing investments in oncology infrastructure across emerging economies, and ongoing clinical trials exploring new cancer indications, all of which are expected to broaden the clinical and commercial potential of proton therapy worldwide.
sales@straitsresearch.com